AURICCHIO, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 3.864
NA - Nord America 3.822
EU - Europa 2.749
SA - Sud America 508
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 86
OC - Oceania 7
Totale 11.187
Nazione #
US - Stati Uniti d'America 3.652
SG - Singapore 1.804
RU - Federazione Russa 1.212
VN - Vietnam 731
CN - Cina 661
BR - Brasile 398
DE - Germania 328
IT - Italia 316
HK - Hong Kong 314
UA - Ucraina 214
FI - Finlandia 196
FR - Francia 143
CA - Canada 103
GB - Regno Unito 100
IE - Irlanda 64
IN - India 56
BD - Bangladesh 53
NL - Olanda 46
AR - Argentina 39
JP - Giappone 35
MX - Messico 34
KR - Corea 30
IQ - Iraq 26
PL - Polonia 26
ZA - Sudafrica 26
TR - Turchia 22
SE - Svezia 20
PH - Filippine 19
CI - Costa d'Avorio 17
LT - Lituania 17
TH - Thailandia 17
ES - Italia 15
PK - Pakistan 15
EC - Ecuador 14
CO - Colombia 13
CZ - Repubblica Ceca 13
ID - Indonesia 13
JM - Giamaica 10
MA - Marocco 10
UY - Uruguay 10
AT - Austria 8
PE - Perù 8
PY - Paraguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IL - Israele 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
CL - Cile 5
KH - Cambogia 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
GT - Guatemala 4
IR - Iran 4
KE - Kenya 4
OM - Oman 4
TW - Taiwan 4
BE - Belgio 3
BO - Bolivia 3
DZ - Algeria 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
AD - Andorra 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BG - Bulgaria 2
BH - Bahrain 2
BJ - Benin 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GF - Guiana Francese 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
VC - Saint Vincent e Grenadine 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GN - Guinea 1
GP - Guadalupe 1
Totale 11.016
Città #
Singapore 877
San Jose 593
Chandler 337
Moscow 313
Hong Kong 306
Ashburn 287
Jacksonville 225
Ho Chi Minh City 224
Beijing 217
Santa Clara 173
Munich 163
Hanoi 146
Los Angeles 106
Lauterbourg 95
Council Bluffs 92
Princeton 91
Millbury 85
The Dalles 84
Helsinki 79
Nanjing 67
Naples 66
Hefei 62
Dallas 53
Wilmington 53
Napoli 48
New York 48
Boston 42
Ottawa 40
Buffalo 39
Haiphong 38
Amsterdam 34
Da Nang 30
Phoenix 30
Tokyo 29
São Paulo 27
Montreal 26
Orem 25
Redondo Beach 24
Brooklyn 23
Nanchang 21
Warsaw 20
Denver 19
Atlanta 17
London 17
Chennai 16
Manchester 16
Rome 15
Seattle 15
Frankfurt am Main 14
San Francisco 14
Turku 14
Houston 13
Johannesburg 13
Milan 13
Poplar 13
Seoul 13
Biên Hòa 12
Boardman 12
Hebei 12
Kronberg 12
Mexico City 12
Norwalk 12
Shenyang 12
Chicago 11
Des Moines 11
Falkenstein 11
Nuremberg 11
Toronto 11
Can Tho 10
Hải Dương 10
Jiaxing 10
Mumbai 10
Porto Alegre 10
Rio de Janeiro 10
Thái Bình 10
Tianjin 10
Baghdad 9
Brasília 9
Brno 9
Falls Church 9
Hanover 9
Belo Horizonte 8
Changsha 8
Montevideo 8
Orange 8
Quảng Ngãi 8
Charlotte 7
Jyväskylä 7
Queens 7
Querétaro 7
Salerno 7
Thái Nguyên 7
Agropoli 6
Bangkok 6
Ipatinga 6
Lawrence 6
Pelotas 6
Secaucus 6
Shanghai 6
Stockholm 6
Totale 5.954
Nome #
Gluten consumption and inflammation affect the development of celiac disease in at-risk children 282
Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. 176
A Celiac Cellular Phenotype, with Altered LPP Sub-Cellular Distribution, Is Inducible in Controls by the Toxic Gliadin Peptide P31-43. 163
Author Correction: Gluten consumption and inflammation affect the development of celiac disease in at-risk children 160
Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes 158
Gliadin peptide P31-43 localizes to endocytic vesicles and interferes with their maturation. 149
The toxic alpha-gliadin peptide 31–43 enters cells without a surface membrane receptor 149
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 148
Pediatric celiac disease patients show alterations of dendritic cell shape and actin rearrangement 148
CELL SHAPE DISCRIMINATES BETWEEN NORMAL AND CELIAC DISEASE (CD) DENDRITIC CELLS (DC). 147
GLIADIN PEPTIDE P31-43 PRESENTS IL15 IN TRANS TO THE NEIGHBOURING CELLS 146
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 145
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 145
M.V. Barone, M. Nanayakkara, D. Zanzi, S. Santagata, G. Lania, V. Discepolo, M. Ten-Eikelder, S. Auricchio 145
Immunogenicity of monococcum wheat in celiac patients 144
Potential celiac patients: a model of celiac disease pathogenesis. 139
Gliadin peptide P31-43 interferes with Hrs localization to endocytic vesicles 138
An undigested gliadin peptide activates innate immunity and proliferative signalling in enterocytes: the role in celiac disease 138
Gliadin peptide P31-43 interferes Hrs (hepatocyte growth factor-regulated tyrosine kinasesubstrate) localization to endocytic vesicles: implications for Celiac Disease (CD) 136
Antibody Profile, Gene Expression and Serum Cytokines in At-Risk Infants before the Onset of Celiac Disease 134
Celiac disease patients dendritic cells have a different shape when interacting with the substrate compared to controls. 134
Susceptibility to deamidation by tissue transglutaminase as a tool to identify immunogenic gliadin peptides in the whole gliadin extracts 133
Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals 133
Adaptive and innate immune responses in celiac disease. 132
Interleukin-10 downregulates inflammation in the small intestinal mucosa of patients with potential celiac disease. 132
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 130
Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin 130
Gliadin activates HLA class I-restricted CD8+ cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. 127
Both innate immunity and growth factor receptor (EGFR) contribute to P31-43 induced proliferation effects in CACO2 cells and celiac enterocytes. 127
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing 125
P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: A role in celiac disease 125
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 124
AN IMMUNODOMINANT DQ8 RESTRICTED GLIADIN PEPTIDE ACTIVATES SMALL INTESTINAL IMMUNE RESPONSE IN "IN VITRO" CULTURED MUCOSA FROM HLA-DQ8 POSITIVE BUT NOT HLA-DQ8 NEGATIVE CELIAC PATIENTS. 123
Altered trafficking of EGF in endocytic proliferation and innate immunity markers in MARSH 0 (M0) biopsies of celiac patients. 123
Flow cytometric and immunohistochemical analysis reveal an increase of CD4+ CD25+ FOXP3+ regulatory T cells in the small intestinal mucosa of potential and untreated coeliac patients. 123
Gliadin-Specific CD8(+) T Cell Responses Restricted by HLA Class I A*0101 and B*0801 Molecules in Celiac Disease Patients 123
In Celiac Disease Patients the In Vivo Challenge with the Diploid Triticum monococcum Elicits a Reduced Immune Response Compared to Hexaploid Wheat 121
Pivotal Role of Inflammation in Celiac Disease 117
Blockage of T-cell costimulation inhibits T-cell action in celiac disease 116
GLIADIN P31-43 PEPTIDE CAN DELAY EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) DECAY INTERIFERING WITH THE ENDOCYTIC PATHWAY 116
Enzymaticactivity hydrolyzing -glutamyl- -naphthylamide in human intestine during adultand fetal life 114
Amines Protect Invitro the Celiac Small-intestine From the Damaging Activity of Gliadin Peptides 114
Lactobacillus paracasei CBA-L74 and its postbiotic inhibit endocytosis in Caco-2 cells 113
FOXP3+ regulatory T-cells are increased in the untreated celiac mucosa and are expanded by gliadin in the in vitro cultured treated mucosa. 113
Brush border and cytosol peptidase activities of human small intestine in normal subjects and celiac patients. 112
Identification of immunodominant epitopes of {alpha}- gliadin in HLA-DQ8 transgenic mice following oral immunization. 111
PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids 110
Gliadin-specific type 1 regulatory T-cells from the intestinal mucosa of treated coeliac patients inhibit pathogenic T-cells. 107
celiac disease assocition with CD8+ T cell responses: identification of a novel gliadin-derived hla-a2 restricted epitope. 106
Gliadin regulates the NK-dendritic cross-talk by HLA-E surface stabilization 105
Gluten sensitivy in a subset of children with insuli-dependent diabetes mellitus. 105
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 epithelial cells. 105
Recombinant human IL-10 suppreses gliadin-dependent T-cell activation in ex vivo cultured celiac intestinal mucosa. 104
EVIDENCE OF CHRONIC INFLAMMATION IN MORPHOLOGICALLY NORMAL SMALL INTESTINE OF CYSTIC FIBROSIS PATIENTS. 103
Production of antiendomysial antibodies after in vitro gliadin challenge of small intestinal biopsy samples from patients with coeliac disease 102
ANTI TISSUE TRANSGLUTAMINASE ANTIBODIES FROM COELIAC PATIENTS INHIBIT TRANSGLUTAMINASE ACTIVITY BOTH IN VITRO AND IN SITU. 101
Celiac disease: role of intestinal compartments in the mucosal immune response. 99
Interleukin 15 mediated epithelial changes in celiac disease 98
Arylamidase activities of brushborder membrane of rat intestine 98
In siblings of coeliac children rectal gluten challenge reveals sensitisation to gluten not restricted to coeliac HLA 97
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 97
Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. 96
Transglutaminase 2 in coeliac disease. 91
ZONULA OCCLUDENS TOXIN (ZOT) INTERFERES WITH THE INDUCION OF NASAL TOLERANCE TO GLIADIN. 91
Second ESPGHAN Capri Meeting: “Genetic factors in functional and structural gastrointestinal disorders”. 91
FAS engagement drives apostosis of enterocytes of coeliac patients 90
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success Story 87
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide 31-43 uptake by epithelial cells. 85
Laser capture microdissection as a tool to study the mucosal immune response in celiac disease 85
Adjuvant effect of lactobacillus casei in a mouse model of gluten sensitivity. 84
INTRANASAL ADMINISTRATION OF ONE ALPHA GLIADIN CAN DOWNREGULATE THE IMMUNE RESPONSE TO WHOLE GLIADIN IN MICE. 82
Low risk of colon cancer in patients with celiac disease 82
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. 81
Gliadin activates mucosal cell-mediated immunity in in vitro cultured rectal mucosa from coeliac patients and a subset of their siblings 80
Characterization of the anti-tissue transglutaminase antibody response in non-obese diabetic mice. 79
SERUM IMMUNOGLOBULINS A AND G, AND MONOCLONAL ANTIBODIES ANTI TISSUE TRANSGLUTAMINASE FROM COELIAC PATIENTS INHIBIT THE CATALYTIC ACTIVITY BOTH IN VITRO AND IN SITU 77
Alpha-Glutamyl-beta-naphthylamide hydrolase of rabbit small intestine. Localization in the brush border and separation fromother brush border peptidases. 77
Automic dysfunction in children with hirschsprung's disease. 76
Evidence for still ongoing convergence evolution of the lactase persistence T -13910 alleles in humans. 76
Dietary proteins and mechanisms of gastrointestinal diseases: gliadin as a model. 75
Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. 74
Terapia del reflusso gastroesofageo 74
Intravenous or intranasal administrtion of gliadin is able to down-regulate the specific immune response in mice. 72
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of coeliac patients 71
EXPRESSION AND ENZYMATIC ACTIVITY OF TRANSGLUTAMINASE IN THE NORMAL AND COELIAC DISEASE 71
Colite ulcerosa e colite allergica 69
Gliadin peptide P31-43 presents in trans IL15. 69
In mice, intravenous or intranasal administration of gliadin is able to down-regulate the specific autoimmune response 68
Enhanced expression of interferon regulatory factor-1 in the mucosa children with coeliac disease. 66
Possible drug targets for coeliac disease. 66
INTERLEUKIN 18 ASSOCIATED MARKERS OF T HELPER CELL TYPE 1 ACTIVITY IN COELIAC DISEASE. 65
Correction of Gliadin Transport Within Enterocytes Through Celiac Disease Serum 65
Bayesian Sequential Pragmatic Cluster Randomized Clinical Trial Design for PrEventive Effect of MEditerranean Diet in Children: PEMED Trial Research Protocol 63
IL-15 drives the specific migration of CD94+ and TCR-gamma delta+ intraepithelial lymphocites in organ cultures of treated celiac patients 63
Delayed diagnosis of coeliac disease increases cancer risk 63
Identification of immunodominant epitopes of (alpha)-gliadin in HLA-DQ8 transgenic mice following oral immunization. 62
Dietary proteins and mechanism of gastrointestinal disease: gliadin as a model. 62
Primo incontro regionale di gastroenterologia pediatrica 62
Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients. 60
Dolore addominale ricorrente ed infezione da Helicobacter pylori: un esempio di revisione critica delle conoscenze 58
Totale 10.726
Categoria #
all - tutte 38.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022481 0 0 0 3 6 22 8 12 74 35 138 183
2022/2023694 105 86 27 48 85 80 3 77 117 29 24 13
2023/2024441 20 68 54 26 18 11 6 90 17 4 95 32
2024/20252.946 171 208 17 9 93 150 347 236 213 291 959 252
2025/20265.176 588 338 541 537 996 180 534 299 700 263 99 101
2026/2027309 94 138 77 0 0 0 0 0 0 0 0 0
Totale 11.187